Morgan Stanley says load up on these 13 AI power infrastructure stocks — including 2 'standout' energy storage plays
Morgan Stanley says it’s time to buy the dip in some beaten-down AI infrastructure stocks.
AI stocks across the board have had a tough stretch in recent week. Here’s the scoreboard on some major AI funds lately: the Global X Artificial Intelligence & Technology ETF (AIQ) is down 17% since June 2;
Read MoreCorgi ETFs: The Small Dog Disrupting an Entire Industry
Corgi ETFs has burst onto the scene as a scrappy, in-house-everything challenger in the ETF world. Ed Rumell, Director and Head of Distribution ETFs at Corgi, grabbed some time with ETF.com’s Dave Nadig at the 2026 ICI ETF Conference to explain how they’re pulling it off.
» Read more about: Corgi ETFs: The Small Dog Disrupting an Entire Industry »
Read MoreYour Social Security Check Won’t Cover the Bills You Already Have. These 4 ETFs Pay the Difference
© shapecharge / Getty Images
The Social Security check hits your account on the same day every month, and every month it comes up short. Groceries cost more. The electric bill runs longer. Your Medicare Part B premium keeps nudging up. The 2026 cost-of-living adjustment was 2.8%,
Despite frustration over high prices, Federal Reserve is expected to keep rates unchanged — for now
Fed watchers Joseph Egelhof and Guneet Dhingra at BNP Paribas Securities say it’s possible Warsh’s central bank will “release the kraken’’ with a “shock rate hike’’ this week; more likely, they wrote in a commentary, policymakers will hold off, reluctant to risk disrupting financial markets that aren’t expecting a rate increase yet.
Read MoreThe Burst
How a $300 Mistake Opened a $1 Billion Market
Novo Nordisk, the pharmaceutical giant behind weight-loss blockbusters Ozempic and Wegovy, just let a key patent on semaglutide lapse in Canada because it forgot to pay a routine maintenance fee, the pharmaceutical equivalent of forgetting to renew your car registration.
As a result, generic versions of semaglutide, the active ingredient in both drugs,
» Read more about: How a $300 Mistake Opened a $1 Billion Market »
Read MoreThe Ivy
Is This The #1 Semi Stock To Buy Now?
AI stocks have been on fire in 2025. After Oracle and other hyperscalers revealed record-breaking capital expenditures, most semiconductor names raced back toward all-time highs. Yet one company that sits at the very heart of chip production has been noticeably absent from the party, ASML.
Despite that enviable position, the stock hasn’t kept pace with the AI rally.
» Read more about: Is This The #1 Semi Stock To Buy Now? »
Read MoreThe Spotlight
Trade Like a Billionaire
Few traders in history have the capacity to seamlessly transition across asset classes, zooming out to see the big macro picture and in to see the minutia of a company’s 10Q but Stan Druckenmiller ranks as one of the few who have succeeded in so doing.
Stan’s thesis has been that the Fed is really in a bind,